跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
KETAMINE INJECTION, BP
Authorized
STANDARD
KETAMINE INJECTION, BP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0ba21241e34c44a5
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
0ba21241e34c44a5
Drug Approval Canada Name
KETAMINE INJECTION, BP
Product Name
KETAMINE INJECTION, BP
Status
Marketed
Status Date
2023-11-14
Original Market Date
2023-11-14
Din
02535645
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Narcotic (CDSA I)
Ahfs
28:04.08
Atc Original
N01AX03 KETAMINE
Atc Name
n 01 ax 03
Aig Number
0131360003
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
KETAMINE (KETAMINE HYDROCHLORIDE)
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0ba21241e34c44a5
Type
Standard
Back to Health Canada Approvals